SIAL Brand
Displaying 18051-18100 of 19750 results.
Sigma Cat.No. | Description |
---|---|
Y0000221 | Fluticasone impurity D European Pharmacopoeia (EP) Reference Standard |
Y0000222 | Moxonidine impurity A, European Pharmacopoeia (EP) Reference Standard |
Y0000223 | Pravastatin impurity A European Pharmacopoeia (EP) Reference Standard |
Y0000224 | Oxfendazole impurity B European Pharmacopoeia (EP) Reference Standard |
Y0000225 | Oxfendazole with impurity D European Pharmacopoeia (EP) Reference Standard |
Y0000226 | Moxonidine European Pharmacopoeia (EP) Reference Standard |
Y0000227 | Meso-rich exametazime European Pharmacopoeia (EP) Reference Standard |
Y0000232 | Dihydralazine for system suitability European Pharmacopoeia (EP) Reference Standard |
Y0000233 | Paroxetine impurity A European Pharmacopoeia (EP) Reference Standard |
Y0000235 | Almagate European Pharmacopoeia (EP) Reference Standard |
Y0000237 | Perindopril impurity A European Pharmacopoeia (EP) Reference Standard |
Y0000238 | Perindopril tert-butylamine European Pharmacopoeia (EP) Reference Standard |
Y0000239 | Celiprolol for peak identification European Pharmacopoeia (EP) Reference Standard |
Y0000240 | Cefapirin sodium European Pharmacopoeia (EP) Reference Standard |
Y0000242 | Glibenclamide impurity B European Pharmacopoeia (EP) Reference Standard |
Y0000244 | Ketobemidone impurity B European Pharmacopoeia (EP) Reference Standard |
Y0000245 | Ketobemidone impurity C European Pharmacopoeia (EP) Reference Standard |
Y0000254 | Econazole for system suitability European Pharmacopoeia (EP) Reference Standard |
Y0000257 | Lactobionic acid European Pharmacopoeia (EP) Reference Standard |
Y0000259 | Diclazuril for system suitability European Pharmacopoeia (EP) Reference Standard |
Y0000261 | Dextromethorphan impurity A European Pharmacopoeia (EP) Reference Standard |
Y0000263 | Prekallikrein activator in albumin European Pharmacopoeia (EP) Reference Standard |
Y0000266 | Flunarizine dihydrochloride for system suitability European Pharmacopoeia (EP) Reference Standard |
Y0000269 | Clazuril for system suitability European Pharmacopoeia (EP) Reference Standard |
Y0000271 | Oxaliplatin European Pharmacopoeia (EP) Reference Standard |
Y0000272 | Oxaliplatin impurity B European Pharmacopoeia (EP) Reference Standard |
Y0000273 | Oxaliplatin impurity C European Pharmacopoeia (EP) Reference Standard |
Y0000274 | Oxaliplatin impurity D European Pharmacopoeia (EP) Reference Standard |
Y0000275 | Dichlorodiaminocyclohexaneplatinum European Pharmacopoeia (EP) Reference Standard |
Y0000276 | Ipratropium impurity A European Pharmacopoeia (EP) Reference Standard |
Y0000279 | Tri-n-butyl phosphate European Pharmacopoeia (EP) Reference Standard |
Y0000280 | Chondroitin sulfate sodium European Pharmacopoeia (EP) Reference Standard |
Y0000281 | Paroxetine hydrochloride hemihydrate European Pharmacopoeia (EP) Reference Standard |
Y0000282 | Tioconazole for system suitability European Pharmacopoeia (EP) Reference Standard |
Y0000284 | Fluticasone propionate European Pharmacopoeia (EP) Reference Standard |
Y0000288 | Piracetam European Pharmacopoeia (EP) Reference Standard |
Y0000297 | Mesalazine European Pharmacopoeia (EP) Reference Standard |
Y0000298 | Fluphenazine octanoate European Pharmacopoeia (EP) Reference Standard |
Y0000300 | Sodium aminosalicylate dihydrate - reference spectrum European Pharmacopoeia (EP) |
Y0000304 | Arginine aspartate European Pharmacopoeia (EP) Reference Standard |
Y0000305 | Asparagine monohydrate European Pharmacopoeia (EP) Reference Standard |
Y0000306 | Azithromycin European Pharmacopoeia (EP) Reference Standard |
Y0000307 | Azithromycin impurity A European Pharmacopoeia (EP) Reference Standard |
Y0000309 | Bumetanide impurity A European Pharmacopoeia (EP) Reference Standard |
Y0000310 | Bumetanide impurity B European Pharmacopoeia (EP) Reference Standard |
Y0000313 | Clofazimine European Pharmacopoeia (EP) Reference Standard |
Y0000314 | Estradiol for peak identification European Pharmacopoeia (EP) Reference Standard |
Y0000315 | Potassium hydrogen aspartate hemihydrate European Pharmacopoeia (EP) Reference Standard |
Y0000316 | Mesna impurity C European Pharmacopoeia (EP) Reference Standard |
Y0000317 | Mesna impurity D European Pharmacopoeia (EP) Reference Standard |